Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Shen

Showing results (1051-1060 of 1,250) with videos related to

Pageof 125
Sort By:
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 17, 2014
Plasma FGF23 levels and heart rate variability in patients with stage 5 CKDL-N Zhang, G Yang, C Cheng, et al.
Cell|October 1, 2020
Phase Separation of Disease-Associated SHP2 Mutants Underlies MAPK HyperactivationGuangya Zhu, Jingjing Xie, Wenna Kong, et al.
Cell Reports|June 25, 2020
Small Molecule Dysregulation of TEAD Lipidation Induces a Dominant-Negative Inhibition of Hippo Pathway SignalingJeffrey K Holden, James J Crawford, Cameron L Noland, et al.
Physical Review Letters|July 30, 2011
Extended magnetic reconnection across the dayside magnetopauseM W Dunlop, Q-H Zhang, Y V Bogdanova, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2012
Discovery of benzodihydroisofurans as novel, potent, bioavailable and brain-penetrant prolylcarboxypeptidase inhibitorsHong C Shen, Fa-Xiang Ding, Jinlong Jiang, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Discovery of benzimidazole pyrrolidinyl amides as prolylcarboxypeptidase inhibitorsHong C Shen, Fa-Xiang Ding, Changyou Zhou, et al.
Molecular Psychiatry|January 28, 2004
Association study of an SNP combination pattern in the dopaminergic pathway in paranoid schizophrenia: a novel strategy for complex disordersQ Xu, Y-B Jia, B-Y Zhang, et al.
Journal of Medicinal Chemistry|June 13, 2020
Discovery of 3-Pyridyl Isoindolin-1-one Derivatives as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) InhibitorsYongfu Liu, Jun Wu, Mingwei Zhou, et al.
Human Molecular Genetics|March 26, 2015
Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility lociSimon G Coetzee, Howard C Shen, Dennis J Hazelett, et al.
Journal of Medicinal Chemistry|April 8, 2025
Discovery of Naphthyridinone Derivatives as Selective and Potent PKMYT1 Inhibitors with Antitumor EfficacyBo Chen, Xiaofeng Liu, Tong Mu, et al.
Pageof 125

Showing results (1051-1060 of 1,250) with videos related to

Sort By:
Pageof 125
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 17, 2014
Plasma FGF23 levels and heart rate variability in patients with stage 5 CKDL-N Zhang, G Yang, C Cheng, et al.
Cell|October 1, 2020
Phase Separation of Disease-Associated SHP2 Mutants Underlies MAPK HyperactivationGuangya Zhu, Jingjing Xie, Wenna Kong, et al.
Cell Reports|June 25, 2020
Small Molecule Dysregulation of TEAD Lipidation Induces a Dominant-Negative Inhibition of Hippo Pathway SignalingJeffrey K Holden, James J Crawford, Cameron L Noland, et al.
Physical Review Letters|July 30, 2011
Extended magnetic reconnection across the dayside magnetopauseM W Dunlop, Q-H Zhang, Y V Bogdanova, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2012
Discovery of benzodihydroisofurans as novel, potent, bioavailable and brain-penetrant prolylcarboxypeptidase inhibitorsHong C Shen, Fa-Xiang Ding, Jinlong Jiang, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Discovery of benzimidazole pyrrolidinyl amides as prolylcarboxypeptidase inhibitorsHong C Shen, Fa-Xiang Ding, Changyou Zhou, et al.
Molecular Psychiatry|January 28, 2004
Association study of an SNP combination pattern in the dopaminergic pathway in paranoid schizophrenia: a novel strategy for complex disordersQ Xu, Y-B Jia, B-Y Zhang, et al.
Journal of Medicinal Chemistry|June 13, 2020
Discovery of 3-Pyridyl Isoindolin-1-one Derivatives as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) InhibitorsYongfu Liu, Jun Wu, Mingwei Zhou, et al.
Human Molecular Genetics|March 26, 2015
Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility lociSimon G Coetzee, Howard C Shen, Dennis J Hazelett, et al.
Journal of Medicinal Chemistry|April 8, 2025
Discovery of Naphthyridinone Derivatives as Selective and Potent PKMYT1 Inhibitors with Antitumor EfficacyBo Chen, Xiaofeng Liu, Tong Mu, et al.
Pageof 125